TNYA · Tenaya Therapeutics, Inc.
$0.70
+0.01 (+0.98%)
At close · Aug 21
Market Cap
$156.36M
Shares
224.23M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| 8-K | 2026-07-02 | 2026-06-29 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-29 | — | |
| 8-K | 2026-05-29 | 2026-05-27 | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-04-16 | 2026-05-27 | |
| 8-K | 2026-03-11 | — | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 8-K | 2026-03-05 | 2026-03-04 | |
| 8-K | 2026-01-30 | 2026-01-26 | |
| 8-K | 2026-01-02 | 2025-12-31 | |
| 8-K | 2025-12-12 | 2025-12-11 | |
| 8-K | 2025-12-11 | — | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-05-30 | 2025-05-28 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-04-18 | 2025-04-15 | |
| DEF 14A | 2025-04-17 | 2025-05-28 | |
| 8-K | 2025-03-28 | 2025-03-27 | |
| 10-K | 2025-03-10 | 2024-12-31 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-03-04 | 2025-03-03 | |
| 8-K | 2025-02-07 | 2025-02-06 | |
| 8-K | 2025-01-28 | 2025-01-24 | |
| 8-K | 2024-12-17 | 2024-12-16 | |
| 8-K | 2024-12-17 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-09-16 | 2024-09-12 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-25 | 2024-07-19 | |
| 8-K | 2024-06-27 | 2024-06-25 | |
| 8-K | 2024-05-31 | 2024-05-30 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | 2024-05-13 | |
| DEF 14A | 2024-04-17 | 2024-05-30 | |
| 10-K | 2024-03-18 | 2023-12-31 | |
| 8-K | 2024-03-18 | — | |
| 8-K | 2024-02-08 | 2024-02-07 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — |
Showing 1–50 of 80 filings
Key facts
CIK
1858848
CUSIP
87990A106
13F (30d)
85 filings
85 filers
Visit website
Investor relations